Fewer hi-tech firms raise more funds in Q3

The trend towards greater investment in later stage companies was confirmed in a report released by Dow Jones VentureOne and Ernst & Young LLP.

October 22, 2007 08:16
3 minute read.


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Seventy-four hi-tech companies raised some $350 million in venture funds during the third quarter, about 10 percent more than 80 companies raised in the second quarter and 39% above the levels raised by 66 companies in the third quarter of 2006, the accounting firm Kesselman & Kesselman, PriceWaterhouseCoopers said in a Money Tree report on Sunday. "The investments that we have seen in Israeli hi-tech companies and the developments that they have made testify to the strength of the venture capital sector in this country," said Joseph Fellus, a partner, advisory and hi-tech practice leader at Kesselman & Kesselman, PwC. "We will continue to see higher numbers in terms of VC money invested in Israeli hi-tech as long as the companies here continue to perform like they are now." On average, the amount raised by these companies was $4.7m. compared to $4m. in the second quarter and $3.8m. a year earlier, the report said, noting that the majority of the funds were invested in companies either in mid or late stage-level development stages, while the remainder was divided between early development stage companies. Sixty-one mid- and late-stage start-ups raised $314m., accounting for 90% of the total amount raised by tech companies during the third quarter, and the largest since the third quarter of 2004, a span of 10 quarters. Most investments by venture capital funds in mid and late-stage start-ups were follow-on investments. Last week the Israel Venture Capital Research Center reported that Israeli technology companies raised $414m. in capital from venture funds and other private investors in the third quarter, a 9% increase from a year earlier. According to that report, the average amount raised by a company fell 9% from a year earlier to $3.82m. Israeli VCs accounted for a substantial piece of the investment action, The Money Tree report said, as they allocated some $160m., or 46% of total third-quarter VC funding, a rise of only $1m. from the second quarter, but of more than $35m. above 2006 figures. According to Money Tree, of the 74 hi-tech companies that raised money here in the third quarter, the 48 that are listed as Israeli accounted for a combined $179m., or 51%, of the VC funds allocated during the period. The remaining companies are listed as foreign-based, with the majority of them from the US. Meanwhile, among the various technology sectors, investment in software companies accounted for $83m. (24%) of the total funds, while life sciences companies raised $72m. (21%) and communications and networks companies raised $63m. (18%). Producers of semiconductors raised $53m., or 15% of the total, while the remaining 22% of the money was raised by Internet or media-based companies. The trend towards greater investment in later stage companies was confirmed in a separate a report released over the weekend by Dow Jones VentureOne and Ernst & Young LLP. According to that study, overall US venture capital investment climbed 8% during the period from year-ago levels to reach $8.07 billion, according to the report. This marked the ninth consecutive quarter of gradual year-over-year growth in dollars invested in the US and is the highest quarterly investment total since the first quarter of 2001. The Dow Jones/E&Y report showed that 635 deals were completed during the quarter, down by 41 deals from the third quarter of 2006. Two-thirds of all capital invested in the third quarter - some $3.8b. - was invested in 224 later rounds, the most invested in late-stage companies since 2001, while combined seed- and first-round investment remained steady year-on-year at $1.74b. These sizable later rounds helped to push the overall median for a venture capital deal in the third quarter to $7.92m., a new record. "The third quarter reinforced that there are innovative and exciting private companies across the industries in which VCs invest," said Joseph Muscat, the US Director of the Ernst & Young Venture Capital Advisory Group. "Fueling this innovation are the larger deal sizes seen this quarter. The overall level of investment and larger deal sizes are suggestive of a continued bullish view of these companies' prospects and liquidity options." The quarterly report also showed surging investment in the Energy and Advanced Specialty Materials & Chemicals sectors, categories that include the majority of today's "clean technology" companies, while Information technology (IT), the largest investment area overall, saw 10% fewer deals and 5% fewer dollars invested than during the same period last year. The data showed that there were 367 completed venture rounds for IT companies, accounting for $3.77b. Energy investments jumped 28% compared to the third quarter of 2006 with $590m. put to work in 33 deals, records on both accounts.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection


Cookie Settings